Staff & Faculty
- Adrienne Ables, PharmD, MMedEdL
- Czarina Acelajado, MD
- Richard A. Ade, RN, MPH
- Lori L. Alexander, MTPW, ELS, MWC
- Randall L. Allen, PharmD
- Marjorie Conner Allen, BSN, JD
- Kelley M. Anderson, PhD, RN, FNP
- Sally Anthony, MS, RN, Paralegal
- Leslie Bakker, RN, MSN
- Paul Ballas, DO
- Dana Bartlett, RN, BSN, MSN, MA, CSPI
- S. Megan Berthold, PhD, LCSW
- Reid Blackwelder, MD, FAAFP
- Michelle Booth, RN, BSN
- Sylvia A. Bower, RN
- Jeffrey Bratberg, PharmD, FAPhA
- Karen Brindza, LPN
- Leslie Bunnage, PhD
- Trever Burgon, PhD
- Ian Theodore Cabaluna, MD
- Nancy Campbell, RN, BSN, PHN
- Sharon Cannon, RN, EdD, ANEF
- Stephen Carek, MD, CAQSM, DipABLM
- Donna Coffman, MD
- Berthina Coleman, RN, MD
- Lisa Concoff Kronbeck, JD
- Michael E. Considine, PsyD, LPC
- Jamielyn Cruz, MD
- Andrea Darby-Stewart, MD
- Marie Davis, RN, IBCLC
- Robert Dean Jr, DO, MBA
- Eric de Belen, MD
- Marilyn Fuller Delong, MA, BSN, RN
- Margaret Donohue, PhD
- Lauren E. Evans, MSW
- Abimbola Farinde, PharmD, PhD
- Alice Yick Flanagan, PhD, MSW
- Mary Franks, MSN, APRN, FNP-C
- William E. Frey, DDS, MS, FICD
- Dana Friedlander, Esq., PA
- Vincenzo Giuliano, MD, DABR, ARMDMS
- Noah Goetzel
- Mark S. Gold, MD, DFASAM, DLFAPA
- Charlene H. Grafton, RN, BS, MS, CCM
- Katherine Greig, MSW, PhD
- Sharon M. Griffin, RN, PhD
- Richard E. Haas, BSN, MSN, EdM, PhD, CRNA, LTC US Army Nurse Corps (Retired)
- Margo A. Halm, RN, PhD, NEA-BC, FAAN
- Flora Harp, PharmD
- Allan G. Hedberg, PhD
- Kathleen Holland, PsyD
- Sharon Holt, DVM, MBA, ADN
- Jacqueline Houtman, RN, MA, CDP
- Lisa Hutchison, LMHC
- Lisa Kathryn Jackson, MA, LPCC, MPH
- Latousha (Tasha) P. Jackson, PharmD, BCPS, QP503A
- Tanika Johnson, EdD, MA, LPC-MHSP, LMHC, NCC, BC-TMH, CCTP
- Beth Johnston, PharmD, BCPS
- John V. Jurica, MD, MPH
- Jessica Kamerer, EdD, MSN, RNC-NICU
- Nicole F. Keehn, RN, MSN, PsyD
- Sara Klockars, PharmD, BCPS
- A. José Lança, MD, PhD
- A. José Lança, MD, PhD
- Jeff Langford, PharmD, BCPS-AQ Cardiology, BCCP
- Susan Engman Lazear, RN, MN
- Patricia Lea, RN, DNP, MSEd, CCRN
- John M. Leonard, MD
- Katrina Lieben, MSN, CNM
- Karen Majorowicz, RN
- Maryam Mamou, BSN, RN, CRRN, CWOCN
- Jamie Marich, PhD, LPCC-S, REAT, RYT-500, RMT
- Kalynn Matisco, APRN, PhD
- Chelsey McIntyre, PharmD
- Chelsey McIntyre, PharmD
- Sandra Mesics, CNM, MSN, RN
- Beyon Miloyan, PhD
- Davina Moss, PhD, CRC, CASAC, NCC
- Elizabeth T. Murane, PHN, BSN, MA
- Usker Naqvi, MD
- Joan Needham, MSEd, RNC
- Michele Nichols, RN, BSN, MA
- Jane C. Norman, RN, MSN, CNE, PhD
- Barry Panzer, PhD, ACSW
- John Peabody, MD
- Peter Peraud, MD
- Amanda Perkins, MSN, DNP
- Teisha Phillips, RN, BSN
- Candace Pierce, DNP, RN, CNE, COI
- Julie Quinn, MD
- Richelle A. Rennegarbe, PhD, RN
- Beth Ribet, PhD, JD
- Mark Rose, BS, MA, LP
- Gayle Roux, PhD, RN, CNS, FNP
- Ronald Runciman, MD
- Anele Runyion, RN, MS
- Dalia Saha, MD
- Suzanne Saldarini, MA, LPC, NCPsyA
- Queenie Samonte, MD
- Evangeline Y. Samples, MS, RDN, LD, EdD
- Mary Schmeida, RN, PhD
- Susan Semb, MSN, CDCES
- Carol Shenold, RN, ICP
- Jennifer Shotlander, LCSW, LCSW-C, LICSW, CEAP
- Shannon E. Smith, MHSC, CST, CSFA
- Jon E. Soskis, BSN, RN
- Linda Strangio, RN, MA, CCRN, CRN
- Mark J. Szarejko, DDS, FAGD
- Diane Thompson, RN, MSN, CDE, CLNC
- Julie Torok-Mangasarian, MA, LMFT, RPM
- James Trent, PhD
- Kevin Val Bismark, MD
- Czarlota Valdenor, MD
- Michael Van Duran, MD
- John Paulo Vergara, MD
- Connie Vogel, PhD, ANP
- Patricia Walters-Fischer, RN, BS
- Junyang Wang, MSc
- Polly Warring, MSPT
- Susan Waterbury, MSN, FNP-BC, ACHPN
- Denise Wheeler, MS, ARNP
- Carol Whelan, APRN
- John J. Whyte, MD, MPH
- Craig Williams, PharmD, FNLA, BCPS
- Richard L. Wynn, BSPharm, PhD
- Natalie Yates, PharmD
- Rosally Zamora, MD
- Lloyd Zimmerman, MD, MPH
Ms. Bower has had a lifelong interest in long-term care, working and volunteering in a variety of settings. She has written program development for case management and was certified in nursing administration and case management. Since her retirement, she has worked in hospice as a volunteer at an inpatient unit. In 1996, Ms. Bower was diagnosed with celiac disease and began gathering research on the history and pathophysiology of the disease. She subsequently authored two books on the topic. She has also lectured extensively on celiac disease to local and national groups. She serves as a board member of the nonprofit Gluten-Free Gang of Central Ohio, which develops, provides, and promotes education, community awareness, and research for those diagnosed with celiac disease and/or gluten intolerance. Her passion is patient education for individuals and families affected by celiac disease.
Her greatest accomplishments are family of three adult children, six grandchildren, and six great-grandchildren.
In addition to her private practice, Dr. Donohue currently teaches at The Chicago School of Professional Psychology in Los Angeles. She is actively involved with the California Psychological Association's Office of Professional Development as a Third Reviewer for courses for continuing education for psychologists. She is a member of the American Psychological Association, the Los Angeles County Psychological Association, and the National Register of Health Service Providers in Psychology.
Dr. Donohue has frequently provided ethical consultation to colleagues in the area of professional boundaries, ethics and psychological assessment, and ethics in professional practice. Her public speaking events have included being a panel presenter in the January 1987 Los Angeles conference on ethics and boundaries for lesbian therapists. She has also presented for the California Psychological Association on the personal impact of head injuries in neuropsychologists with Jonathan Greene, PhD, in 2006.
Dr. Donohue has published articles on Tarasoff notification and racism; quality evaluation in health care; benchmarking access to outpatient services in managed health organizations; treatment of anxiety in young children; and the development of assessment techniques in evaluations of young children and assessing organizational productivity and quality.
Previously acting as a faculty member at Capella University and Northcentral University, Dr. Yick Flanagan is currently a contributing faculty member at Walden University, School of Social Work, and a dissertation chair at Grand Canyon University, College of Doctoral Studies, working with Industrial Organizational Psychology doctoral students. She also serves as a consultant/subject matter expert for the New York City Board of Education and publishing companies for online curriculum development, developing practice MCAT questions in the area of psychology and sociology. Her research focus is on the area of culture and mental health in ethnic minority communities.
Dr. Frey retired from the United States Army Dental Corps in 1989 after 22 years of service. Throughout the course of his professional career, he has continuously practiced dentistry, the first 7 years as a general dentist and the past more than 40 as a periodontist. His military experience included the command of a networked Dental Activity consisting of five dental clinics. In his last assignment, he was in charge of a 38-chair facility. Colonel Frey was selected by the Army to serve on two separate occasions as the Chair of the Periodontal Department in Army General Dentistry Residency Training Programs.
Dr. Frey is the founder and president of Perio Plus, a practice management firm specializing in creating individually-designed hygiene and periodontal care programs for general dentists. He is also the creator of the Inspector Gum patient education series.
He is an author and inventor who has published more than 1,000 peer-reviewed scientific articles, 20 text books, popular-general audience books, and physician practice guidelines. Dr. Gold was co-inventor of the use of clonidine in opioid withdrawal and the dopamine hypothesis for cocaine addiction and anhedonia. Both revolutionized how neuroscientists and physicians thought about drugs of abuse, addiction, and the brain. He pioneered the use of clonidine and lofexidine, which became the first non-opioid medication-assisted therapies. His first academic appointment was at Yale University School of Medicine in 1978. Working with Dr. Herb Kleber, he advanced his noradrenergic hyperactivity theory of opioid withdrawal and the use of clonidine and lofexidine to ameliorate these signs and symptoms. During this time, Dr. Gold and Dr. Kleber also worked on rapid detoxification with naloxone and induction on to naltrexone.
Dr. Gold has been awarded many state and national awards for research and service over his long career. He has been awarded major national awards for his neuroscience research including the annual Foundations Fund Prize for the most important research in Psychiatry, the DEA 30 Years of Service Pin (2014), the American Foundation for Addiction Research’s Lifetime Achievement Award (2014), the McGovern Award for Lifetime Achievement (2015) for the most important contributions to the understanding and treatment of addiction, the National Leadership Award (NAATP) from addiction treatment providers for helping understand that addiction is a disease of the brain, the DARE Lifetime Achievement Award for volunteer and prevention efforts, the Silver Anvil from the PR Society of America for anti-drug prevention ads, the PRIDE and DARE awards for his career in research and prevention (2015), and the PATH Foundation’s Lifetime Achievement Award (2016) as one of the “fathers” of addiction medicine and MAT presented to him by President Obama’s White House Drug Czar Michael Botticelli. He was awarded Distinguished Alumni Awards at Yale University, the University of Florida, and Washington University and the Wall of Fame at the University of Florida College of Medicine. Gold was appointed by the University President to two terms as the University’s overall Distinguished Professor, allowing him to mentor students and faculty from every college and institute. The University of Florida College of Medicine’s White Coat Ceremony for new medical students is named in his honor.
Since his retirement as a full-time academic in 2014, Dr. Gold has continued his teaching, mentoring, research, and writing as an Adjunct Professor in the Department of Psychiatry at Washington University and an active member of the Clinical Council at the Washington University School of Medicine’s Public Health Institute. He regularly lectures at medical schools and grand rounds around the country and at international and national scientific meetings on his career and on bench-to-bedside science in eating disorders, psychiatry, obesity, and addictions. He continues on the Faculty at the University of Florida College of Medicine, Department of Psychiatry as an Emeritus Distinguished Professor. He has traveled extensively to help many states develop prevention, education, and treatment approaches to the opioid crisis.
Dr. Greig has worked in the fields of social work and counseling for more than 30 years. Her specialty areas include depression, anxiety, relationship issues, and Christian counseling. Dr. Greig is a certified Critical Incident Stress Management (CISM) consultant, Substance Abuse Professional (SAP), and Employee Assistance Program (EAP) specialist.
In her eight years of clinical work, Ms. Jackson has written more than 2,500 mental health assessments and reviewed hundreds of clinical records for medical necessity. She continues her clinical work as a Behavioral Health Care Manager in a managed care setting reviewing clinical documentation from mental health providers throughout the state of New Mexico. In 2017, Ms. Jackson received a Master of Public Health degree with a concentration in Healthcare management and Policy from Benedictine University (Illinois). She continues her work in behavioral health as the CEO and Senior Clinical Advisor with ENVIVE Solutions, LLC.
He is a former CME surveyor and Chair of the CME Committee at the Illinois State Medical Society and former surveyor for, and member of, the Accreditation Review Committee of the Accreditation Council for CME. As Chief Medical Office for Riverside Medical Center, he was administratively responsible for Quality Improvement, Patient Safety, and Continuing Medical Education for the hospital.
Dr. Lança has participated in international courses and conferences on neurosciences. He has contributed to a better understanding of the mechanisms underlying the ontogenetic development of the brain opiatergic system. As a research scientist at the Addiction Research Foundation (ARF) in Toronto, he initiated research on the functional role played by dopaminergic cell transplants on alcohol consumption, leading to the publication of the first research reports on cell transplantation and modulation of an addictive behavior. Subsequently, he also investigated the role played by other neurotransmitter systems in the limbic system and mechanisms of reward, co-expression of classical neurotransmitters and neuropeptides and potential role in neuropsychiatric disorders.
He is an Assistant Professor in the Department of Pharmacology at the Faculty of Medicine and at the Faculty of Dentistry at the University of Toronto. He was the Program Director for Undergraduate Studies in the Department of Pharmacology of the University of Toronto. He has developed clinical pharmacology courses for the Radiation Sciences and Chiropody Programs of The Michener Institute for Health Sciences at the University of Toronto, where he also lectures both pharmacology courses and holds a Faculty position.
Dr. Lança's commitment to medical education started while a medical student, teaching in the Department of Histology and Embryology, where he became cross-appointed after graduation. In Toronto, he has contributed extensively to curriculum development and teaching of pharmacology to undergraduate, graduate and medical students. He has developed an integrated approach to clinical pharmacology, and has contributed to an evidence-based teaching of Herbal Medications in clinical pharmacology. He is also the author of six chapters in medical pharmacology textbooks.
Dr. Lança participated in international courses and conferences on neurosciences. He has contributed to a better understanding of the mechanisms underlying the ontogenetic development of the brain opiatergic system. As a research scientist at the Addiction Research Foundation (ARF) in Toronto, he initiated research on the functional role played by dopaminergic cell transplants on alcohol consumption, leading to the publication of the first research reports on cell transplantation and modulation of an addictive behavior. Subsequently, he also investigated the role played by other neurotransmitter systems in the limbic system and mechanisms of reward, co-expression of classical neurotransmitters and neuropeptides and potential role in neuropsychiatric disorders.
He is an Assistant Professor in the Department of Pharmacology and Toxicology at the Faculty of Medicine and at the Faculty of Dentistry at the University of Toronto, where he lectures and directs several undergraduate and postgraduate pharmacology and clinical pharmacology courses. He was the Program Director for Undergraduate Studies in the Department of Pharmacology and Toxicology of the University of Toronto. He has developed clinical pharmacology courses for the Medical Radiation Sciences and Chiropody Programs of The Michener Institute for Health Sciences at the University of Toronto.
Dr. Lança’s commitment to medical education started while a medical student, teaching in the Department of Histology and Embryology, where he became cross-appointed after graduation. In Toronto, he has contributed extensively to curriculum development and teaching of pharmacology to undergraduate, graduate, and medical students.
He has authored research and continuing education in peer-reviewed publications and is the author of six chapters in pharmacology textbooks. Dr. Lança has conducted research in various areas including neuropharmacology, pharmacology of alcoholism and drug addiction, and herbal medications.
He has developed and taught courses and seminars in continuing medical education and continuing dental education. His commitment to continuing education emphasizes an interdisciplinary approach to clinical pharmacology.
Ms. Mamou has worked in various rehabilitation settings and has first-hand experience of how pressure ulcers impact patients' recovery and quality of life. She has held positions as staff nurse, unit coordinator, educator, and director of nursing in home health care. She has been involved in developing and implementing several staff education programs in a variety of settings. She was most recently employed as a wound ostomy and continence nurse at East Alabama Medical Center in Opelika, Alabama.
Dr. Moss’ research interests are opioid use, the medical-patient relationship, and neonatal abstinence syndrome. She has written articles and continuing education courses and has also been a contributing author in three academic textbooks. Dr. Moss is an adjunct professor at New York University’s Applied Psychology Department and a Volunteer Research Assistant Professor at The State University of NY at Buffalo, Jacob’s School of Medicine.
Her nursing experience includes hospital nursing on pediatric, medical, and surgical units. She lived for 15 years in a village in Eastern Papua New Guinea providing medical and linguistic/literacy services for the villagers. She was a public health nurse for a year with the Brooklyn, New York Health Department and 20 years with the Shasta County Public Health Department in Redding, California. As a public health nursing director, she developed response plans for environmental and health issue disasters for both Shasta County and adjacent Tehama County Public Health Departments.
Dr. Panzer received a PhD with Distinction in social work from Columbia University and has served as a clinical instructor at Downstate Medical Center (at State University of new York) and adjunct professor at Columbia University. His post-graduate training includes family therapy, cognitive-behavior therapy, and child and adolescent nutrition. He has published in the areas of sudden infant death syndrome, crisis intervention, and ADHD. Dr. Panzer’s interest in childhood obesity dates to 2003 and since then he has published articles in the American Journal of Orthopsychiatry, ICAN: Infant, Child, and Adolescent Nutrition, and ADHD Report. He has also made presentations at major conferences, including for the American Academy of Pediatrics, the American Psychological Association, and the National Association of Social Workers. Dr. Panzer is passionate about educating and motivating colleagues to become involved in caring for families of obese youth.
For twenty years she was psychiatric nurse consultant and coordinator of psychiatric nursing consultation at San Francisco General Hospital. She was Assistant Clinical Professor in Mental Health, Community and Administrative Nursing at the University of California, San Francisco. She created and co-chaired a National Psychiatric Consultation/Liaison Conference in 1987, which provided continuing education in nursing. This conference meets annually and has subsequently become an international conference.
She created a brief curriculum and practicum in consultation/liaison nursing for graduate nursing students at UCSF that is currently being practiced. As a psychiatric nurse consultant, she assisted non-psychiatric nurses in the hospital to assimilate and integrate psychological principles into their practice. During this time, she developed a protocol for management of acute post-traumatic stress response. This protocol was adopted by the hospital as a standard care plan for nursing management of patients with acute post-traumatic stress response in the non-psychiatric areas of the hospital.
Ms. Runyion has published and spoken nationally. She was listed in Who’s Who in American Nursing in 1991-92 and 1996-97. Currently, she is a self-employed consultant and writer.
Mrs. Shenold served as the Continuum of Care Manager for Vencor Oklahoma City, coordinating quality review, utilization review, Case Management, Infection Control, and Quality Management. During that time, the hospital achieved Accreditation with Commendation with the Joint Commission, with a score of 100.
Mrs. Shenold was previously the Infection Control Nurse for Deaconess Hospital, a 300-bed acute care facility in Oklahoma City. She is an active member of the Association for Professionals in Infection Control and Epidemiology (APIC). She worked for the Oklahoma Foundation for Medical Quality for six years.
Mr. Soskis wishes to recognize the years-long contributions to this work by Rick Dart, MD, PhD, Director of Rocky Mountain Poison and Drug Center; Jeffrey Bernstein, MD, Medical Director of the South Florida Poison Information Center, Miami; and Ed Hall, MD, South Georgia Surgical Associates.
Ms. Thompson has been employed in diabetes care since 2001, when she was hired as a diabetes case manager. After the completion of 1,000 hours of education to diabetes patients, Ms. Thompson earned her certification as a diabetes educator in 2003. From 2006 to 2018, Ms. Thompson was the Director of Diabetes Healthways at Munroe Regional Medical Center in Ocala, Florida. As the director of the diabetes center, Ms. Thompson was responsible for the hospital diabetes clinicians, hospital wound care clinicians, and out-patient education program. Today, she is the nurse manager of a heart, vascular, and pulmonary ambulatory clinic at Metro Health System in Cleveland, Ohio. Ms. Thompson has also lectured at the local, state, and national level regarding diabetes and the hospital management of hyperglycemia. Ms. Thompson is a member of the ADA, AADE, Florida Nurses Association, and the National Alliance of Certified Legal Nurse Consultants.
Ms. Thompson acknowledges her family as her greatest accomplishment. She is a wife of more than 30 years and a mother of a daughter and son, of which she is very proud. Ms. Thompson credits her husband for the support needed to set a goal and achieve it. He has been by her side through nursing school and completion of her Bachelor's degree and Master's degree, which she was awarded in 2015 from Jacksonville University in Florida.
In addition to her clinical roles, Ms. Waterbury continues to play an active role in educating and mentoring nurses and healthcare professionals. She has been a faculty member of the University of Phoenix since 2015, teaching in the nurse practitioner and MSN programs. She develops and presents educational programs for a variety of healthcare organizations and community groups.
Prior to this, Dr. Whyte was in the Immediate Office of the Director at the Agency for Healthcare Research Quality. He served as Medical Advisor/Director of the Council on Private Sector Initiatives to Improve the Safety, Security, and Quality of Healthcare. Prior to this assignment, Dr. Whyte was the Acting Director, Division of Medical Items and Devices in the Coverage and Analysis Group in the Centers for Medicare & Medicaid Services (CMS). CMS is the federal agency responsible for administering the Medicare and Medicaid programs. In his role at CMS, Dr.Whyte made recommendations as to whether or not the Medicare program should pay for certain procedures, equipment, or services. His division was responsible for durable medical equipment, orthotics/prosthetics, drugs/biologics/therapeutics, medical items, laboratory tests, and non-implantable devices. As Division Director as well as Medical Officer/Senior Advisor, Dr. Whyte was responsible for more national coverage decisions than any other CMS staff.
Dr. Whyte is a board-certified internist. He completed an internal medicine residency at Duke University Medical Center as well as earned a Master’s of Public Health (MPH) in Health Policy and Management at Harvard University School of Public Health. Prior to arriving in Washington, Dr. Whyte was a health services research fellow at Stanford and attending physician in the Department of Medicine. He has written extensively in the medical and lay press on health policy issues.